Abryl Laboratories Achieves Milestone with Regadenoson Injection ANDA Approval
pharmanewspress Abryl Laboratories announced the approval of its Abbreviated New Drug Application (ANDA) for Regadenoson Injection in pre-filled syringes.…
Abryl Laboratories announced the approval of its Abbreviated New Drug Application (ANDA) for Regadenoson Injection in pre-filled syringes.…